由于输卵管怀孕而经过甲状腺素治疗后的再接收
Yossi Bart1, Noam Regev1, Uria Shani1
1Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.
概括
对于输卵管怀孕而言,在甲状腺激素治疗后的再入院是常见的 (43.8%). 关键的风险因素包括先前的盆腔炎症疾病和高初始人体胆性腺激素 (hCG) 水平,这也预测了手术需求.
科学领域:
- 生殖医学 生殖医学
- 妇科 妇科 妇科 妇科
- 药理治疗 药理治疗
背景情况:
- 宫外怀孕,特别是输卵管怀孕,需要有效的管理.
- 甲托雷克萨特是用于输卵管怀孕的常见药物治疗.
- 了解再接收因素对于优化患者护理和资源配置至关重要.
研究的目的:
- 为了确定在输卵管怀孕中接受甲状腺治疗后与患者再入院相关的重大风险因素.
- 分析治疗前患者特征与治疗后结果之间的相关性.
主要方法:
- 一项回顾性研究分析了511名经过医学治疗的输卵管怀孕患者在两个三级中心.
- 患者人口统计和临床数据的比较,这些患者是重新入院的,不是重新入院的.
- 使用后勤回归分析来确定重新接收的独立风险因素.
主要成果:
- 甲状腺素治疗后的再入院率为43.8% (224/511名患者).
- 重新入院的重大风险因素包括盆腔炎症病史和治疗前血清人类胆固醇激素 (hCG) 水平>2000 mIU/mL.
- 较高的治疗前hCG水平显示了与再入院,输卵管破裂和需要手术的剂量依赖的关联.
结论:
- 之前的盆腔炎症疾病和治疗前血清hCG水平升高是输卵管怀孕后甲状腺激素再接收的独立预测因素.
- 治疗前血清hCG水平也与输卵管破裂和手术干预的增加率相关.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Phase II Reactions: Methylation Reactions
186
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
186
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
Meiosis II
183.3K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
183.3K


